Literature DB >> 15726418

BRCA1 variants in a family study of African-American and Latina women.

Roberta McKean-Cowdin1, Heather Spencer Feigelson, Lucy Y Xia, Celeste Leigh Pearce, Duncan C Thomas, Daniel O Stram, Brian E Henderson.   

Abstract

We sequenced the entire coding region of BRCA1 to improve our understanding of the frequency and nature of BRCA1 variants in African-American and Latina women identified from a multiethnic cohort in Los Angeles, California. The study included 109 African-American and 140 Latina sibships from families with two or more cases of breast or ovarian cancer among first-degree relatives. BRCA1 was sequenced in 278 breast or ovarian cancer cases and 229 unaffected sisters. The proportion of cases with known disease-causing mutations was low (0.72, 95% confidence interval: 0-1.7%). In total, 33 sequence variants were identified, including two protein truncation mutations, one deletion, and six silent and 24 missense variants. Two novel rare variants were identified that appeared to act as benign polymorphisms. Four rare variants may be unique to women of African descent based on existing literature, and three have been described exclusively in Latina women. The frequency of common variants was similar for cases and controls, but the frequency of common variants for African-American women significantly differed from those previously described for Caucasian women. We believe this to be the largest study of high-risk African-American and Latina women sequenced for variants in the BRCA1 gene to date.

Entities:  

Mesh:

Year:  2005        PMID: 15726418     DOI: 10.1007/s00439-004-1240-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  48 in total

1.  Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Authors:  Steven A Narod; Marie-Pierre Dubé; Jan Klijn; Jan Lubinski; Henry T Lynch; Parviz Ghadirian; Diane Provencher; Ketil Heimdal; Pal Moller; Mark Robson; Kenneth Offit; Claudine Isaacs; Barbara Weber; Eitan Friedman; Ruth Gershoni-Baruch; Gad Rennert; Barbara Pasini; Theresa Wagner; Mary Daly; Judy E Garber; Susan L Neuhausen; Peter Ainsworth; Hakan Olsson; Gareth Evans; Michael Osborne; Fergus Couch; William D Foulkes; Ellen Warner; Charmaine Kim-Sing; Olufunmilayo Olopade; Nadine Tung; Howard M Saal; Jeffrey Weitzel; Sofia Merajver; Marion Gauthier-Villars; Helena Jernstrom; Ping Sun; Jean-Sebastien Brunet
Journal:  J Natl Cancer Inst       Date:  2002-12-04       Impact factor: 13.506

2.  Consed: a graphical tool for sequence finishing.

Authors:  D Gordon; C Abajian; P Green
Journal:  Genome Res       Date:  1998-03       Impact factor: 9.043

3.  Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

Authors:  A M Dunning; M Chiano; N R Smith; J Dearden; M Gore; S Oakes; C Wilson; M Stratton; J Peto; D Easton; D Clayton; B A Ponder
Journal:  Hum Mol Genet       Date:  1997-02       Impact factor: 6.150

4.  Frequency of breast cancer attributable to BRCA1 in a population-based series of American women.

Authors:  B Newman; H Mu; L M Butler; R C Millikan; P G Moorman; M C King
Journal:  JAMA       Date:  1998-03-25       Impact factor: 56.272

Review 5.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

6.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

Authors:  D F Easton; D T Bishop; D Ford; G P Crockford
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

Review 7.  Breast cancer genetics in African Americans.

Authors:  Olufunmilayo I Olopade; James D Fackenthal; Georgia Dunston; Michael A Tainsky; Francis Collins; Carolyn Whitfield-Broome
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

Review 8.  Inherited breast and ovarian cancer.

Authors:  C I Szabo; M C King
Journal:  Hum Mol Genet       Date:  1995       Impact factor: 6.150

9.  On the use of familial aggregation in population-based case probands for calculating penetrance.

Authors:  Colin B Begg
Journal:  J Natl Cancer Inst       Date:  2002-08-21       Impact factor: 13.506

10.  Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families.

Authors:  A Osorio; A Barroso; B Martínez; A Cebrián; J M San Román; F Lobo; M Robledo; J Benítez
Journal:  Br J Cancer       Date:  2000-04       Impact factor: 7.640

View more
  16 in total

1.  Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.

Authors:  Marcelo A Carvalho; Sylvia M Marsillac; Rachel Karchin; Siranoush Manoukian; Scott Grist; Ramona F Swaby; Turan P Urmenyi; Edson Rondinelli; Rosane Silva; Luis Gayol; Lisa Baumbach; Rebecca Sutphen; Jennifer L Pickard-Brzosowicz; Katherine L Nathanson; Andrej Sali; David Goldgar; Fergus J Couch; Paolo Radice; Alvaro N A Monteiro
Journal:  Cancer Res       Date:  2007-02-15       Impact factor: 12.701

Review 2.  Common BRCA1 and BRCA2 mutations in breast cancer families: a meta-analysis from systematic review.

Authors:  Furu Wang; Qiaoqiao Fang; Zhen Ge; Ningle Yu; Sanxiao Xu; Xiangyong Fan
Journal:  Mol Biol Rep       Date:  2011-06-04       Impact factor: 2.316

3.  Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical-pathological features in BRCA carriers and non-carriers.

Authors:  Xavier Gabaldó Barrios; Mª Desamparados Sarabia Meseguer; Miguel Marín Vera; Ana Isabel Sánchez Bermúdez; José Antonio Macías Cerrolaza; Pilar Sánchez Henarejos; Marta Zafra Poves; Mª Rosario García Hernández; Encarna Cuevas Tortosa; Ángeles Aliaga Baño; Verónica Castillo Guardiola; Pedro Martínez Hernández; Isabel Tovar Zapata; Enrique Martínez Barba; Francisco Ayala de la Peña; José Luis Alonso Romero; José Antonio Noguera Velasco; Francisco Ruiz Espejo
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

4.  Estimating risks for variants of unknown significance according to their predicted pathogenicity classes with application to BRCA1.

Authors:  J G Dowty; E Lee; R McKean-Cowdin; B E Henderson; L Bernstein; G Ursin; J L Hopper
Journal:  Breast Cancer Res Treat       Date:  2014-01-31       Impact factor: 4.872

5.  BRCA1 and BRCA1 Genes and Inherited Breast and/or Ovarian Cancer: Benefits of Genetic Testing.

Authors:  Kumaravel Somasundaram
Journal:  Indian J Surg Oncol       Date:  2011-03-11

6.  Family history and age at onset of breast cancer in Hispanic and non-Hispanic white women.

Authors:  Betsy Risendal; Lisa M Hines; Carol Sweeney; Martha L Slattery; Anna R Giuliano; Kathy B Baumgartner; Karen Curtin; Tim E Byers
Journal:  Cancer Causes Control       Date:  2008-09-26       Impact factor: 2.506

7.  Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women.

Authors:  Lisa M Hines; Betsy Risendal; Martha L Slattery; Kathy B Baumgartner; Anna R Giuliano; Tim Byers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-10       Impact factor: 4.254

8.  Reproductive Endocrinologists' Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers.

Authors:  Allison L Goetsch; Catherine Wicklund; Marla L Clayman; Teresa K Woodruff
Journal:  J Genet Couns       Date:  2015-11-14       Impact factor: 2.537

9.  Screening of the BRCA1 gene in Brazilian patients with breast and/or ovarian cancer via high-resolution melting reaction analysis.

Authors:  Eneida Santos de Oliveira; Bárbara Luisa Soares; Sara Lemos; Reginaldo Cruz Alves Rosa; Angélica Nogueira Rodrigues; Leandro Augusto Barbosa; Débora de Oliveira Lopes; Luciana Lara dos Santos
Journal:  Fam Cancer       Date:  2016-04       Impact factor: 2.375

10.  Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results.

Authors:  Sharon E Plon; Diana M Eccles; Douglas Easton; William D Foulkes; Maurizio Genuardi; Marc S Greenblatt; Frans B L Hogervorst; Nicoline Hoogerbrugge; Amanda B Spurdle; Sean V Tavtigian
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.